Please login to the form below

Not currently logged in
Email:
Password:

EAGLES

This page shows the latest EAGLES news and features for those working in and with pharma, biotech and healthcare.

AZ bags key lung cancer approval for Imfinzi

AZ bags key lung cancer approval for Imfinzi

AZ is also expecting read-outs from The KESTREL and EAGLE trials of Imfinzi with and without tremelimumab in head and neck cancer.

Latest news

More from news
Approximately 2 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2016 Deal Watch November 2016

    To address this Eagle plans to establish a Biologics Innovation Center in Cambridge, Massachusetts. ... acquisition - company. 80. Arsia Therapeutics/ Eagle Pharmaceuticals. viscosity reducing technology and formulation know-how with "biobetter" focus.

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Asset acquisition - products. 121. † Eagle Pharmaceuticals/ Teva. EP-3102 - bendamustine hydrochloride rapid infusion product - CLL, indolent B-cell NHL.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Eagle Genomics appoints executive chairman Eagle Genomics appoints executive chairman

    Eagle Genomics appoints executive chairman. Anthony Finbow replaces Alan Barrell. UK-based Eagle Genomics has appointed Anthony Finbow as its new executive chairman. ... Finbow had previously been working in an advisory capacity at Eagle Genomics,

  • Bioinformatics firm Eagle adds to senior team Bioinformatics firm Eagle adds to senior team

    Bioinformatics firm Eagle adds to senior team. Appoints Michael Reynolds and promotes Will Spooner and Glenn Proctor. ... Abel Ureta-Vidal, CEO of Eagle, said: “ These appointments are critical to Eagle's ongoing success.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • The power of the patient

    The power of the patient. In this episode, we talk to Matt Eagles who was diagnosed with Parkinson's Disease aged just eight.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics